Case Study: Prohemia® Increases Hemoglobin 10% in 1 Month in female with Stage 3 Kidney Disease

Prohemia® case study shows dramatic blood building effects in an 77-year-old female with stage 3 kidney disease and anemia.

METHODS: An 77-year-old female with anemia agreed to participate in a case study to help demonstrate the efficacy of Prohemia® to support healthy blood levels. Four (4) Prohemia® capsules were ingested daily for two (2) months. Hematocrit and hemoglobin levels were measured after two months of continuous Prohemia® use.

RESULTS: Following two months of Prohemia® use, the subject’s hematocrit and hemoglobin improved to healthy normal levels.

 

Hemoglobin
(grams/dL)

GFR (mL/minute/1.73 m2)

Before Prohemia®

10.5(anemic)

33

After Prohemia®

11.1
(normal)

39

CONCLUSION: Although limited to a single subject, this anemic subject showed  improvements in blood levels at one (1) months. Specifically, hemoglobin levels increased  10%. Of note was the improvement in GFR. This anemic subject’s blood levels returned to healthy normal levels after two months of Prohemia® use.

This case study also agrees with previous published clinical studies that showed potent increases in erythropoietin (EPO) levels following ingestion of the ingredients found in Prohemia®.

*Results may vary and the case study results cannot be expected in 100% of Prohemia users.